Heart Disease Comorbidity Research Published in Vascular Failure, Wins Award
NQ Score
84/100
N1 Content Completeness
90
Key facts
- Heart Disease Comorbidity Research Published in Vascular Failure, Wins Award
- Joint research by Eucalia and Osaka University visualizing the 10-year comorbidities of heart disease using Eucalia Data Lake was published in 'Vascular Failure' and won the Excellent Presentation Award.
- Source: PR TIMES
- Date: Fri Jun 05 2026 00:30:02 GMT+0900 (Japan Standard Time)
Direct answer
Joint research by Eucalia and Osaka University visualizing the 10-year comorbidities of heart disease using Eucalia Data Lake was published in 'Vascular Failure' and won the Excellent Presentation Award.
- Citation
- Heart Disease Comorbidity Research Published in Vascular Failure, Wins Award (Fri Jun 05 2026 00:30:02 GMT+0900 (Japan Standard Time)), PR TIMES
- Source
- PR TIMES
- Date
- Fri Jun 05 2026 00:30:02 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
Joint research by Eucalia and Osaka University visualizing the 10-year comorbidities of heart disease using Eucalia Data Lake was published in 'Vascular Failure' and won the Excellent Presentation Award.
AI Analysis
Frequently Asked Questions
- Q: In which journal was Eucalia's joint research paper published?
- A: The paper was published in 'Vascular Failure', the journal of the Japanese Society for Vascular Failure.
- Q: Who did Eucalia collaborate with for this research?
- A: Eucalia collaborated with Professor Hironori Nakagami from the Graduate School of Medicine at Osaka University.
- Q: What data platform was used for the research?
- A: The research utilized 'Eucalia Data Lake', which is based on anonymized electronic medical record data held by Eucalia.
- Q: What is the sample size of the research?
- A: The research included data from 407 cases across 3 affiliated medical institutions of Eucalia.
- Q: When did the research receive the Excellent Presentation Award?
- A: It received the award at the 11th Annual Meeting of the Japanese Society for Vascular Failure held on April 19, 2026.